Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer

It was to explore the clinical efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) targeted drugs combined with hyaluronic acid-gadolinium sesquioxide-nanoparticles (HA-Gd2O3-NPs) in non-small cell lung cancer (NSCLC). In this study, 70 patients with stage IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuan, Jin, Ting, Wang, Likun, Zhao, Erlin, Xiao, Xuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805885/
https://www.ncbi.nlm.nih.gov/pubmed/34818973
http://dx.doi.org/10.1080/21655979.2021.2009969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805885/
https://www.ncbi.nlm.nih.gov/pubmed/34818973
http://dx.doi.org/10.1080/21655979.2021.2009969

Ejemplares similares